Perjeta, also known as pertuzumab, is a crucial advancement in treating HER2-positive certain types of cancer. This drug works by blocking a distinct pathway that helps cancer cells proliferate. Differing from some alternative HER2-targeted therapies, pertuzumab avoids directly block the HER2 rec